Literature DB >> 16757594

Distribution and invasiveness of Streptococcus pneumoniae serotypes in Switzerland, a country with low antibiotic selection pressure, from 2001 to 2004.

Andreas Kronenberg1, Phillip Zucs, Sara Droz, Kathrin Mühlemann.   

Abstract

To describe the serotype-specific epidemiology of colonizing and invasive Streptococcus pneumoniae isolates, which is important for vaccination strategies, we analyzed a total of 2,388 invasive and 1,540 colonizing S. pneumoniae isolates collected between January 2001 and December 2004 within two nationwide surveillance programs. We found that the relative rank orders of the most frequent serotypes (serotypes 1, 3, 4, 6B, 7F, 14, 19F, and 23F) differed among invasive and colonizing isolates. Serotypes 1, 4, 5, 7F, 8, 9V, and 14 had increased invasive potential, and serotypes/serogroups 3, 6A, 7, 10, 11, 19F, and 23F were associated with colonization. The proportion of pediatric serotypes was higher among children < 5 years old (48.5%) and persons > 64 years old (34.1%) than among other age groups (29.1%); it was also higher in West Switzerland (40.2%) than in other geographic regions (34.7%). Likewise, serotype-specific proportions of penicillin-resistant isolates for types 6B, 9V, 14, and 19F were significantly higher in West Switzerland. The relative frequency of pediatric serotypes corresponded with antibiotic consumption patterns. We conclude that the epidemiology of invasive and colonizing S. pneumoniae isolates is influenced by the serotype-specific potential for invasiveness, and therefore, surveillance programs should include colonizing and invasive S. pneumoniae isolates. Antibiotic selection pressure determines the serotype distribution in different age groups and geographic regions and therefore the expected direct and indirect effects of the 7-valent conjugate vaccine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16757594      PMCID: PMC1489397          DOI: 10.1128/JCM.00275-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Variation in antibiotic use in the European Union.

Authors:  O Cars; S Mölstad; A Melander
Journal:  Lancet       Date:  2001-06-09       Impact factor: 79.321

2.  Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential.

Authors:  Angela B Brueggemann; David T Griffiths; Emma Meats; Timothy Peto; Derrick W Crook; Brian G Spratt
Journal:  J Infect Dis       Date:  2003-04-04       Impact factor: 5.226

3.  Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland.

Authors:  Massimo Filippini; Giuliano Masiero; Karine Moschetti
Journal:  Health Policy       Date:  2005-11-10       Impact factor: 2.980

4.  Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

Authors:  W P Hausdorff; J Bryant; P R Paradiso; G R Siber
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

5.  Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old.

Authors:  R K Syrjänen; T M Kilpi; T H Kaijalainen; E E Herva; A K Takala
Journal:  J Infect Dis       Date:  2001-07-06       Impact factor: 5.226

6.  Nationwide surveillance of nasopharyngeal Streptococcus pneumoniae isolates from children with respiratory infection, Switzerland, 1998-1999.

Authors:  Kathrin Mühlemann; Hans C Matter; Martin G Täuber; Thomas Bodmer
Journal:  J Infect Dis       Date:  2003-01-29       Impact factor: 5.226

7.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Authors:  Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

Review 8.  Importance of dose and duration of beta-lactam therapy in nasopharyngeal colonization with resistant pneumococci.

Authors:  J J Canet; J Garau
Journal:  J Antimicrob Chemother       Date:  2002-12       Impact factor: 5.790

Review 9.  The successful clone: the vector of dissemination of resistance in Streptococcus pneumoniae.

Authors:  K P Klugman
Journal:  J Antimicrob Chemother       Date:  2002-12       Impact factor: 5.790

10.  Invasive pneumococcal disease in children: geographic and temporal variations in incidence and serotype distribution.

Authors:  Willam P Hausdorff
Journal:  Eur J Pediatr       Date:  2002-10-01       Impact factor: 3.183

View more
  31 in total

1.  Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype.

Authors:  Raquel Sá-Leão; Francisco Pinto; Sandra Aguiar; Sónia Nunes; João A Carriço; Nelson Frazão; Natacha Gonçalves-Sousa; José Melo-Cristino; Hermínia de Lencastre; Mário Ramirez
Journal:  J Clin Microbiol       Date:  2011-01-26       Impact factor: 5.948

2.  Use of the Agilent 2100 bioanalyzer for rapid and reproducible molecular typing of Streptococcus pneumoniae.

Authors:  Lucy J Hathaway; Silvio Brugger; Alina Martynova; Suzanne Aebi; Kathrin Mühlemann
Journal:  J Clin Microbiol       Date:  2007-01-03       Impact factor: 5.948

3.  Population structure of hyperinvasive serotype 12F, clonal complex 218 Streptococcus pneumoniae revealed by multilocus boxB sequence typing.

Authors:  Alexey V Rakov; Kimiko Ubukata; D Ashley Robinson
Journal:  Infect Genet Evol       Date:  2011-08-25       Impact factor: 3.342

Review 4.  Humoral immune responses to Streptococcus pneumoniae in the setting of HIV-1 infection.

Authors:  Lumin Zhang; Zihai Li; Zhuang Wan; Andrew Kilby; J Michael Kilby; Wei Jiang
Journal:  Vaccine       Date:  2015-06-30       Impact factor: 3.641

5.  Clonal distribution of invasive pneumococci, Czech Republic, 1996-2003.

Authors:  Helena Zemlickova; Pavla Urbaskova; Vladislav Jakubu; Jitka Motlova; Martin Musilek; Bohumir Prochazka
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

6.  Multiple colonization with S. pneumoniae before and after introduction of the seven-valent conjugated pneumococcal polysaccharide vaccine.

Authors:  Silvio D Brugger; Pascal Frey; Suzanne Aebi; Jason Hinds; Kathrin Mühlemann
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

7.  An unusual pneumococcal sequence type is the predominant cause of serotype 3 invasive disease in South Africa.

Authors:  Kedibone M Mothibeli; Mignon du Plessis; Anne von Gottberg; Linda de Gouveia; Peter Adrian; Shabir A Madhi; Keith P Klugman
Journal:  J Clin Microbiol       Date:  2009-11-04       Impact factor: 5.948

8.  Age-specific cluster of cases of serotype 1 Streptococcus pneumoniae carriage in remote indigenous communities in Australia.

Authors:  H Smith-Vaughan; R Marsh; G Mackenzie; J Fisher; P S Morris; K Hare; G McCallum; M Binks; D Murphy; G Lum; H Cook; V Krause; S Jacups; A J Leach
Journal:  Clin Vaccine Immunol       Date:  2008-12-17

9.  Detection of Streptococcus pneumoniae strain cocolonization in the nasopharynx.

Authors:  Silvio D Brugger; Lucy J Hathaway; Kathrin Mühlemann
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

10.  Isolation site influences virulence phenotype of serotype 14 Streptococcus pneumoniae strains belonging to multilocus sequence type 15.

Authors:  Zarina Amin; Richard M Harvey; Hui Wang; Catherine E Hughes; Adrienne W Paton; James C Paton; Claudia Trappetti
Journal:  Infect Immun       Date:  2015-09-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.